Upgrade to SI Premium - Free Trial

Kiora Pharmaceuticals (KPRX)

2.60 +0.01 (0.39%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/26 *Est.)

Latest Headlines

Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation August 19, 2026 7:02 AM - StreetInsider Form 8-K KIORA PHARMACEUTICALS For: Aug 19 August 19, 2026 7:01 AM - SEC Filing Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: ADAR1 Capital Management, LLC August 14, 2026 5:04 PM - SEC Filing Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: Nantahala Capital Management, LLC August 14, 2026 4:49 PM - SEC Filing Form SCHEDULE 13G KIORA PHARMACEUTICALS Filed by: PERCEPTIVE ADVISORS LLC August 10, 2026 11:59 AM - SEC Filing Kiora Pharmaceuticals (KPRX) Tops Q2 EPS by 17c August 7, 2026 7:34 AM - StreetInsider Form 8-K KIORA PHARMACEUTICALS For: Aug 07 August 7, 2026 7:03 AM - SEC Filing Form 10-Q KIORA PHARMACEUTICALS For: Jun 30 August 7, 2026 7:03 AM - SEC Filing Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update August 7, 2026 7:03 AM - StreetInsider Form 4 KIORA PHARMACEUTICALS For: Jul 01 Filed by: Tosca Melissa July 2, 2026 4:47 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jul 01 Filed by: Strem Brian M. July 2, 2026 4:47 PM - SEC Filing Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium July 2, 2026 7:02 AM - StreetInsider Form 8-K KIORA PHARMACEUTICALS For: Jun 18 June 18, 2026 7:03 AM - SEC Filing Kiora Pharmaceuticals reports KIO-300 reduced seizure activity in lab model June 18, 2026 7:03 AM - StreetInsider Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model June 18, 2026 7:02 AM - StreetInsider Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: Stengone Carmine N. June 12, 2026 4:16 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: Parsons Erin June 12, 2026 4:16 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: Shapiro Aron June 12, 2026 4:16 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: Hollander David June 12, 2026 4:16 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: Walters-Hoffert Lisa June 12, 2026 4:16 PM - SEC Filing Form 4 KIORA PHARMACEUTICALS For: Jun 10 Filed by: TYLE PRAVEEN June 12, 2026 4:14 PM - SEC Filing Form 8-K KIORA PHARMACEUTICALS For: Jun 10 June 11, 2026 6:02 AM - SEC Filing Form 424B3 KIORA PHARMACEUTICALS May 28, 2026 5:52 PM - SEC Filing Form EFFECT KIORA PHARMACEUTICALS May 26, 2026 6:04 AM - SEC Filing Full Article List